The role of soluble receptor for advanced glycation end-products (sRAGE) in the general population and patients with diabetes mellitus with a focus on renal function and overall outcome.

Critical Reviews in Clinical Laboratory Sciences
Mieke SteenbekeMarijn M Speeckaert

Abstract

Isoforms of the receptor for advanced glycation end-product (RAGE) protein, which lack the transmembrane and the signaling (soluble RAGE or sRAGE) domains are hypothesized to counteract the detrimental action of the full-length receptor by acting as a decoy, and they provide a potential tool to treat RAGE-associated diseases. Multiple studies have explored the relationship between sRAGE and endogenous secretory RAGE and its polymorphism and obesity, metabolic syndrome, atherosclerosis, kidney function, and increased mortality in the general population. In addition, sRAGE may be a key player in the pathogenesis of diabetes mellitus and its microvascular (e.g. kidney disease) as well as macrovascular (e.g. cardiovascular disease) complications. In this review, we focus on the role of sRAGE as a biomarker in these specific areas. As there is a lack of an underlying unifying hypothesis about how sRAGE changes according to the disease condition or risk factor, there is a call to incorporate all three players of the AGE-RAGE axis into a new universal biomarker/risk marker: (AGE + RAGE)/sRAGE. However, the measurement of RAGE in humans is not practical as it is a cell-bound receptor for which tissue is required for analysis. A high AG...Continue Reading

References

Oct 17, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·I EbiharaH Koide
Dec 1, 2001·Journal of the American Society of Nephrology : JASN·Carmine ZoccaliLorenzo Salvatore Malatino
Jun 19, 2002·Genes and Immunity·M A HofmannA M Schmidt
Nov 27, 2002·Circulation·Loredana G BucciarelliAnn Marie Schmidt
Jul 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yali ChenKevan C Herold
Feb 26, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Colomba FalconeDiego Geroldi
Jun 4, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Chunmei ChengYasuhiko Yamamoto
Jul 23, 2005·Annals of the New York Academy of Sciences·Jasper W L HartogAndries J Smit
Oct 15, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Hidenori KoyamaYoshiki Nishizawa
Feb 21, 2006·Diabetes Research and Clinical Practice·Shigeru SakuraiHiroshi Yamamoto
Feb 24, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Marta KalousováTomás Zima
Jul 21, 2007·Free Radical Biology & Medicine·Eleonora DevangelioGiovanni Davì
Jan 10, 2008·The Journal of Clinical Endocrinology and Metabolism·Su-Yen Goh, Mark E Cooper
Mar 12, 2008·Nature Clinical Practice. Endocrinology & Metabolism·Shi Fang YanAnn Marie Schmidt
Jul 4, 2008·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Giuseppe Danilo NorataAlberico Luigi Catapano
Jul 8, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Angela RaucciMarco E Bianchi
Sep 9, 2008·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Naoto KatakamiYoshimitsu Yamasaki
Sep 16, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Richard D SembaLinda P Fried
Jan 22, 2009·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Jason B LindseyDarren K McGuire

❮ Previous
Next ❯

Citations

Aug 28, 2021·International Journal of Molecular Sciences·Franziska DiekmannGeorg Hansmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.